other material
confidence high
sentiment neutral
materiality 0.40
Insight Molecular Diagnostics Inc. (IMDX): auditor change — Oncocyte dismisses Withum, engages Marcum as independent auditor for FY 2023
Insight Molecular Diagnostics Inc.
- Withum dismissed as independent registered public accounting firm on September 29, 2023.
- Audit Committee approved Marcum LLP as new auditor for fiscal year ending December 31, 2023.
- Withum's reports for FY 2021 and FY 2022 were unqualified; no disagreements reported.
- A material weakness in internal controls was identified and remediated prior to June 30, 2023.
- Withum furnished a letter agreeing with the company's disclosures, attached as Exhibit 16.1.